RABEKOT-LS Capsule is a prescription medicine designed to provide relief from acid-related stomach problems, including acid reflux, heartburn, and peptic ulcers. It combines the acid-reducing power of Rabeprazole with the gut-motility enhancing effect of Levosulpiride, helping improve digestion and overall comfort.
Benefits of RABEKOT-LS Capsule
-
Helps relieve symptoms of heartburn and acid reflux
-
Reduces excess acid production in the stomach
-
Supports healing of peptic ulcers
-
Improves stomach and intestinal motility, aiding digestion
Side Effects of RABEKOT-LS Capsule
-
Mild headache or dizziness
-
Nausea or vomiting
-
Stomach pain or diarrhea
-
Weakness or fatigue
Most side effects are temporary. Consult your doctor if they persist or worsen
How to Use RABEKOT-LS Capsule
-
Take this medicine exactly as prescribed by your doctor
-
Swallow the capsule whole with water
-
Best taken before meals or as directed by your healthcare provider
-
Do not chew, crush, or break the capsule
How It Works
Rabeprazole, a proton pump inhibitor, reduces the amount of acid produced in the stomach
Levosulpiride, a prokinetic, improves the movement of the stomach and intestines to prevent acid reflux and discomfort
Points to Avoid
-
Avoid alcohol consumption while taking this medicine
-
Avoid skipping doses or stopping the medicine early without consulting your doctor
-
Avoid spicy, fatty, or caffeinated foods which may worsen symptoms
-
Avoid driving or operating machinery if you feel dizzy or sleepy
Safety Advice and Precautions
-
Consult your doctor if you are pregnant, planning pregnancy, or breastfeeding
-
Inform your doctor about any kidney or liver conditions before starting
-
Use with caution in patients with existing medical conditions
-
Store in a cool, dry place away from direct sunlight
-
Keep out of reach of children
RABEKOT-LS Capsule is a reliable choice for managing acid-related disorders, ensuring relief and promoting digestive health when used responsibly under medical guidance



Reviews
There are no reviews yet.